-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cognition Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Cognition Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$7.04M, a 49% decline year-over-year.
- Cognition Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$31.1M, a 36.9% decline year-over-year.
- Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$25.8M, a 20.5% decline from 2022.
- Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$21.4M, a 82.6% decline from 2021.
- Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$11.7M, a 49.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)